Rare Skin Hardening in Newborns May Begin Before Birth, Perspective Argues

A rare and often fatal skin condition of critically ill newborns, long described as a disorder that develops after birth, may in some cases begin before the baby is even delivered. That is the central proposal of a new Perspective article published in Discover Pediatrics, which argues that congenital sclerema neonatorum, a form of the disease in which diffuse skin hardening is already present at birth, could represent one manifestation of a continuum running from chronic fetal compromise in the womb to acute deterioration during labor and delivery. The author, Rakesh Kotha, is careful to frame the proposal as a hypothesis-generating framework rather than an established mechanism, and the article repeatedly stresses that no causal relationship has been demonstrated.

Sclerema neonatorum is a severe form of panniculitis, an inflammatory disorder of the fat beneath the skin. In its classic form it is characterized by waxy, rigid, cold induration of the skin and subcutaneous tissues, most often affecting the trunk, buttocks, thighs, and upper arms while sparing the palms, soles, and genitalia. It is classically described as occurring within the first week of life and is typically associated with prematurity, sepsis, hypothermia, shock, and respiratory failure. Despite advances in neonatal intensive care, the severe variety of the condition remains associated with high neonatal mortality. Most of the published literature treats it as a postnatal process, but isolated reports have described neonates with diffuse skin induration involving the joints, edema, and varying degrees of antenatal compromise already evident at birth, suggesting that in some instances the disease process may begin before delivery.

A key contribution of the Perspective is a proposed distinction between two presentations that are often conflated. The article defines congenital sclerema neonatorum as diffuse skin induration clearly evident immediately at birth, whereas early-onset disease refers to induration developing during the first several postnatal days after an initially unaffected appearance at delivery. The author argues that this division matters because not all descriptions of sclerema should be interpreted as congenital, and failing to make the distinction will overestimate the support for an antenatal cause. Many published reports describe early-onset rather than unequivocally congenital disease, and several did not document evidence of antecedent fetal compromise at all. In some cases the antenatal history, placental examination, and fetal surveillance data were incomplete or unavailable, so chronic fetal compromise should be regarded as one biologically plausible pathway rather than a universal prerequisite.

The published evidence base remains extremely limited, consisting almost entirely of isolated case reports and small case series. The most frequently cited report is that of Molteni and colleagues, who described neonates presenting with diffuse skin induration and congenital joint contractures evident immediately after birth, together with evidence of chronic fetal distress, suggesting a possible antenatal contribution to the disease process. Subsequent reports have described either congenital presentations or very early-onset disease occurring during the first few postnatal days. Across these reports, several common clinical characteristics recur, including severe neonatal illness, respiratory compromise, diffuse skin induration, and rapid clinical deterioration. The author argues that these shared observations justify further investigation into whether antenatal factors contribute to disease development in a subset of affected neonates, while acknowledging that the evidence does not uniformly support an antenatal origin for all cases.

To provide clinical context, the article presents an illustrative composite scenario, explicitly derived from clinical experience and published observations rather than a formally documented case. In this scenario, a term neonate was delivered with diffuse skin induration, tight abdominal skin, generalized edema, and joint contractures evident immediately after birth. Chest radiography demonstrated severe bilateral pulmonary opacification suggestive of severe meconium aspiration syndrome. The infant was profoundly hypothermic and developed rapid cardiorespiratory collapse despite intensive resuscitation. Retrospective review suggested reduced fetal movements during the 48 hours preceding delivery, which are recognized indicators of possible placental dysfunction and fetal compromise. Placental examination, skin biopsy, and autopsy findings were unavailable, and the author emphasizes that the scenario should be interpreted solely as a hypothesis-generating example rather than evidence of diagnosis or causality.

The pathophysiological reasoning behind the proposal draws on the unusual biology of neonatal fat. The pathogenesis of sclerema neonatorum remains incompletely understood, but neonatal adipose tissue contains relatively high proportions of saturated fatty acids together with immature brown adipose tissue compared with adult fat. Under conditions of hypothermia, acidosis, hypoperfusion, and severe systemic illness, these characteristics may contribute to tissue hardening. The Perspective proposes that chronic fetal hypoxia may contribute to progressive metabolic and circulatory stress before delivery, but it states plainly that no direct experimental evidence currently demonstrates that chronic fetal hypoxia alters neonatal adipose tissue composition, promotes adipose crystallization, or directly initiates the disease. The proposed mechanism is therefore described as biologically plausible but unproven. The article also notes that persistent intrauterine compromise may reduce fetal activity and contribute to a fetal akinesia-like sequence characterized by restricted movement and joint contractures, while superimposed acute peripartum insults, including meconium passage, aspiration, respiratory failure, hypothermia, circulatory collapse, and metabolic acidosis, may further exacerbate tissue injury in susceptible neonates.

On this basis the author outlines a proposed acute-on-chronic cascade, presented as a framework for future studies rather than a known pathogenic model. In this model, chronic placental insufficiency results in sustained fetal hypoxemia, leading to reduced fetal movements and progressive metabolic and circulatory stress that increases adipose tissue vulnerability. Superimposed acute peripartum deterioration can then result in skin induration and systemic deterioration with the clinical picture of congenital sclerema neonatorum. The article stresses that this clinical setting is a hypothesis-generating framework and should not be construed as a definite pathogenic relationship, and that detailed antenatal studies, rigorous placental assessment, histopathological analysis, and biochemical investigations are imperative as the only means to substantiate or disprove the hypothesized model.

Diagnosis of congenital sclerema neonatorum is difficult because the disorder can be clinically indistinguishable from other neonatal conditions, and the article argues that a multidisciplinary approach involving neonatologists, obstetricians, dermatopathologists, radiologists, and perinatal pathologists is warranted. Prominent clinical features include burn-like skin of a wood-like consistency, joint contractures, lower extremity edema, respiratory distress, circulatory collapse, severe hypothermia, acidotic blood, and poor perfusion of the arms and legs. Antenatal indicators of fetal compromise should be sought, including fetal growth restriction, abnormal umbilical or middle cerebral artery Doppler studies, maternal hypertensive disorders, placental insufficiency, and signs of chronic fetal hypoxemia, although the author notes these findings should be regarded as supportive rather than diagnostic because they have not been consistent across reported cases. Skin biopsy remains the most reliable diagnostic method, with typical findings including needle-shaped clefts due to dissolved triglycerides, thickened fibrous septa, minimal inflammation, and absence of significant fat necrosis. The condition must also be distinguished from subcutaneous fat necrosis of the newborn, which presents as localized nodular or plaque-like erythematous lesions and shows lobular panniculitis with multinucleated giant cells, granulomatous inflammation, fat necrosis, and calcification. Sclerema neonatorum carries a high mortality from systemic insult and multiple organ failure, whereas subcutaneous fat necrosis is generally self-limiting, though it can cause clinically significant hypercalcemia. The article states that no existing evidence supports congenital sclerema as an antenatal variant of subcutaneous fat necrosis, and that the literature instead supports treating them as distinct entities.

A recurring theme is the lack of systematic placental examination in previously reported cases, which the author identifies as one of the most significant limitations of the existing literature. The article recommends that when congenital sclerema neonatorum is suspected, the placenta should ideally be preserved immediately after delivery before disposal to permit complete gross and histopathological examination according to the Amsterdam Placental Workshop Group Consensus recommendations, including assessment of placental weight, cord insertion, placental and maternal vascular malperfusion, chronic inflammatory changes, and abnormalities of placental maturation. Maternal vascular malperfusion may be reflected by distal villous hypoplasia, accelerated villous maturation, decidual arteriopathy, and placental infarction, while fetal vascular malperfusion may be identified by avascular villi, fetal vascular thrombosis, and related lesions. Chronic inflammatory lesions such as villitis of unknown etiology and chronic histiocytic intervillositis may provide additional evidence of longstanding placental dysfunction. Other timing markers may help, including meconium-laden macrophages within the fetal membranes, which typically first appear in the amnion and extend to the chorion and decidua over hours to days, and an elevated nucleated red blood cell count, which may suggest chronic or subacute fetal hypoxia. The article cautions that placental abnormalities are common in many birth defects and cannot be diagnostic of congenital sclerema neonatorum, but they can serve as clinicopathological correlation for future investigations.

The Perspective also considers why the condition may be under-recognized. It is exceptionally rare, and most neonatologists, obstetricians, dermatologists, and perinatal pathologists may never encounter it in their careers. Congenital presentations may be incorrectly classified as generalized edema, hydrops fetalis, congenital contracture syndromes, severe neonatal sepsis, metabolic disorders, or postmortem skin changes, and hardening of the skin after death may be interpreted as an artifact of the dying process rather than true sclerema in the absence of confirmatory histology. Rapid cardiorespiratory deterioration and early death often limit full diagnostic evaluation, including skin biopsy and autopsy. The author proposes future priorities including multicenter registries with standardized reporting of antenatal history, fetal surveillance, placental examination, and dermatopathological confirmation, along with experimental studies of neonatal adipose tissue biology under chronic fetal hypoxia, acidosis, and hypoperfusion. The article explicitly does not propose changes to current obstetric management guidelines, noting that because of the condition’s rarity it is not possible to conclude that earlier recognition or intervention would prevent disease occurrence. Ultimately, the author hopes the Perspective will increase diagnostic focus, stimulate placental evaluation, and encourage the collaborative investigation needed to determine whether congenital sclerema neonatorum represents a distinct clinicopathological entity or one phenotypic manifestation within a broader spectrum of severe neonatal disease.

Subject of Research: A Perspective proposing a possible antenatal origin of congenital sclerema neonatorum through chronic fetal compromise and acute peripartum deterioration

Article Title: Congenital sclerema neonatorum associated with chronic fetal compromise and acute peripartum deterioration

Article References: Kotha, R. (2026). Congenital sclerema neonatorum associated with chronic fetal compromise and acute peripartum deterioration. Discover Pediatrics, 1(1), Article 6. https://doi.org/10.1007/s44571-026-00006-4

Image Credits: AI Generated

DOI: 10.1007/s44571-026-00006-4

Keywords: sclerema neonatorum, neonatal panniculitis, congenital disease, fetal hypoxia, placental pathology, perinatal medicine, skin induration, neonatal intensive care, subcutaneous fat necrosis, Amsterdam Placental Consensus, fetal compromise, dermatopathology